Effects Of Dutasteride On Risk Reduction Of Acute Urinary Retention Relapse Following Trial Without Catheter

PHASE4TerminatedINTERVENTIONAL
Enrollment

276

Participants

Timeline

Start Date

March 31, 2007

Conditions
Benign Prostatic Hyperplasia
Interventions
DRUG

Dutasteride

Trial Locations (25)

EN5 3DJ

GSK Clinical Trials Call Center, Barnet

BA1 1BX

GSK Clinical Trials Call Center, Bath

B15 2TH

GSK Clinical Trials Call Centre, Birmingham

BD2 0NA

GSK Clinical Trials Call Center, Bradford

BS2 8HW

GSK Clinical Trials Call Center, Bristol

CH2 1UL

GSK Clinical Trials Call Center, Chester

CO4 5JL

GSK Clinical Trials Call Center, Colchester

CW1 4QJ

GSK Clinical Trials Call Center, Crewe

DE22 3NE

GSK Clinical Trials Call Centre, Derby

EH4 2XU

GSK Clinical Trials Call Center, Edinburgh

G51 4TF

GSK Clinical Trials Call Center, Glasgow

HU16 5JQ

GSK Clinical Trials Call Center, Hull

LS9 7TF

GSK Clinical Trials Call Center, Leeds

LE5 4PW

GSK Clinical Trials Call Center, Leicester

E11 1NR

GSK Clinical Trials Call Center, London

NE7 7DN

GSK Clinical Trials Call Center, Newcastle upon Tyne

NG5 1PB

GSK Clinical Trials Call Center, Nottingham

OL1 2JH

GSK Clinical Trials Call Center, Oldham

L39 2AZ

GSK Clinical Trials Call Center, Ormskirk

PL6 8DH

GSK Clinical Trials Call Center, Plymouth

SG1 4AB

GSK Clinical Trials Call Center, Stevenage

SR4 7TP

GSK Clinical Trials Call Center, Sunderland

B75 7RR

GSK Clinical Trials Call Center, Sutton Coldfield

TQ2 7AA

GSK Clinical Trials Call Center, Torquay

WF1 4DG

GSK Clinical Trials Call Center, Wakefield

Sponsors

Lead Sponsor

All Listed Sponsors
lead

GlaxoSmithKline

INDUSTRY